Ila Singh, MD, PhD
Department or Service
- Texas Medical Center
Chief, Division of Laboratory Medicine
Texas Children's Hospital
Chief, Pathology Informatics
Program Director, Clinical Informatics Fellowship
Director of Laboratories, Austin Specialty Care Clinic
Professor, Pathology & Immunology, Baylor College of Medicine
|New York Presbyterian Hospital||residency||Clinical Pathology||1999|
|Stanford University School of Medicine||post-doctoral fellow||Jane Coffins Child Fellowship||1996|
|Yale University||PhD||Doctor of Philosophy||1993|
|University of Bombay, Topiwala National Medical College||MBBS||Bachelor of Medicine, Bachelor of Surgery||1987|
Dr. Singh serves as Chief of Laboratory Medicine, and Chief of Pathology Informatics at Texas Children’s Hospital, and as tenured Professor of Pathology & Immunology at Baylor College of Medicine. She is the Program Director for the Clinical Informatics fellowship. Dr. Singh completed her M.D. at the University of Bombay, and her Ph.D. at Yale University. She served as a Jane Coffin Childs Fellow at Stanford University and completed her Clinical Pathology residency training at Columbia University Medical Center in New York City.
She is dual board-certified in Clinical Pathology and in Clinical Informatics. She is interested in testing and reporting for COVID-19, and the impact of the pandemic on laboratory testing in general. Dr. Singh has special expertise in Laboratory Test Utilization Management/Stewardship, as evidenced by her involvement in creating the first Clinical and Laboratory Standards Institute (CLSI) document on Test
Utilization, and her membership on the national committee on Lab Test Utilization and Stewardship that co-authored the consensus document on the subject. Her current research is focused on using Artificial Intelligence/Deep Learning approaches to determine risk stratification, prescriptive analytics, better utilization of healthcare resources, and optimization of treatment protocols. She is the founder of TRUU-Lab, a national initiative to change the names of clinical lab tests to those that are more standardized and easily understood by clinicians.
|Academy of Clinical Laboratory Physicians and Scientists||Member|
|American Society for Microbiology||Member|
|Association of Pathology Informatics||Member|
|College of American Pathologists||Member|
Procop GW, Daley AT, Baron J, Collier C, Hamilton MS, Hess NL, Lewandrowski K, McLawhon RW, Perrotta PL, Schifman RB, Schmidt RL, Singh I, (2017) Developing and Managing a Medical Laboratory (Test) Utilization Management Program, 1st Edition, CLSI GP49-ED1:2017.
Dickerson JA, Fletcher AH, Procop G, Keren DF, Singh IR, Garcia JJ, Carpenter RB, Miles J, Jackson B, Astion ML, (2017) Transforming Laboratory Utilization Review into Laboratory Stewardship: Guidelines by the PLUGS® National Committee for Laboratory Stewardship, J Appl Lab Med, 2:259-268.
Auerbach MR, Shu C, Kaplan A, Singh IR. (2003) Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting. Proc Natl Acad Sci USA 100(20), 11678-83. Commentary to article: Rein A., (2003) Proc. Natl. Acad. Sci. USA, 100: 11929-11930.
Singh IR, Crowley RA, Brown PO (1997) High-resolution functional mapping of a cloned gene by genetic footprinting. Proc Natl Acad Sci USA 94(4), 1304.
View All Publications:
Choosing Wisely Champion Award, ASCP Choosing Wisely and ABIM Foundation, 2018, for exemplary work to reduce overuse and improve the United States health care system
The Laboratory Medicine Faculty Teaching Award, Columbia University
Dr. D. H. Dudha Memorial First Prize in Medicine, University of Bombay